Senior insider sale
Chief Executive Officer at TENAYA THERAPEUTICS, INC. — senior position signals high conviction
$15.8K
22.23K shares
What this filing means
ALI FARAZ plans to sell 22.23K shares of TENAYA THERAPEUTICS, INC. valued at approximately $15.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/18/2026ACC: 0001193125-26-354513
DirectorOfficer· Chief Executive Officer
Since Jul 2021
22.23K
Shares to sell
$15.8K
Approx. market value
59.51K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Unit
N/A
8/17/2026
59.51KTotal acquired59.51K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/17/2026 | Restricted Stock Unit N/A | 59.51K | — |
| Total | 59.51K | ||
Planned & Completed Dispositions1
Nasdaq Capital MktPlanned
Units to sell
22.23K
Market value
$15.8K
8/17/2026
Total
Units
22.23K
Value
$15.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/17/2026 | 22.23K | $15.8K | Nasdaq Capital Mkt | Planned |
| Total | 22.23K | $15.8K | ||